Our campaign is now complete. 196 supporters helped us raise US$116,331.00
Visit the charity's profile
The campaign has now expired but it's not too late to support this charity.
Visit the charity's profileIF YOU ARE HAVING ISSUES WITH DONATING THROUGH THIS PAGE, please try:
or http://www.cancer.ucla.edu/sisters
Please support Fierce Sisters Fight Cancer's TEAM FOR OUR SISTERS: RACE TO END OVARIAN CANCER inaugural campaign, as we complete a 13.1-mile walk for the LA Marathon's Charity Challenge. All funds raised will be directed to the Ovarian Cancer Research Program conducted in the UCLA Translational Oncology Research Lab.
Help us reach our goal of $75,000 and kick in a $25,000 DONATION from an anonymous Angel donor to get us to $100K!!!
To donate, please click the pink "Give Now" button.
To register for the LA Marathon Charity Challenge (half marathon), please CLICK HERE . On the form, choose "UCLA Jonsson Cancer Center Foundation" as your team.
Our two Fierce Sisters journey started the day Elisabeth received a Stage IVb Ovarian Cancer diagnosis. From symptom to advanced high-grade serous carcinoma, it was a 22 terrifying days. Soon after, both Elisabeth and her sister Susan were identified as BRCA1 mutation carriers. Susan underwent preventive surgeries only to discover that she, too had the beginnings of this disease. It is hard to express the despair and powerlessness one feels to learn that there is no "cure" for ovarian cancer. Only 17% of advanced-stage patients are still alive by year five, and of those patients who do survive, there is a 90-95% recurrence rate. Also, BRCA1 carriers have a very high lifetime risk for breast and ovarian cancer, and there is no early detection test.
Their despair turned to hope when they met Dr. Gottfried E. Konecny, an internationally recognized leader in ovarian cancer research, a physician-scientist, and a professor of medicine at the Geffen School of Medicine at UCLA. Given his extensive research, Dr. Konecny put Elisabeth on a life-saving clinical trial of PARP-Inhibitors, a new targeted drug treatment known to not only extend the life of advanced ovarian cancer patients. It also holds the promise of treating ovarian cancer for the first time as a chronic disease rather than as a death sentence!
Our goal is to support Dr. Konecny's vital research at the UCLA Translational Oncology Lab in developing a method for early detection and to support his research into PARP-Inhibitors and other novel targeted treatment therapies.
So the work begins! Let us walk together to raise funds for the lives of all our sisters, mothers, daughters, grandmothers, aunts, and girlfriends! Please DONATE to "Fierce Sisters Fight Cancers TEAM FOR OUR SISTERS inaugural campaign for the LA Half Marathon on November 7, 2021!
Much Love and deepest gratitude from Elisabeth and Susan for all your support!
Please FOLLOW & SHARE our progress:
TWITTER @2FierceSisters
FACEBOOK @FierceSistersFightCancer
INSTAGRAM @FierceSistersFightCancer
*Strict adherence to COVID-19 safety rules and regulations will apply. The LA Marathon is scheduled to take place on Sunday, November 7, 2021. In the event the marathon is postponed or cancelled, your registration will be carried over to the new Marathon date.
* Charities pay a small fee for our service. Find out how much it is and what we do for it.